Pancreatic Cancer — The Silent Killer
Herbs, Supplements and Alternative Medicine: What Science Says

The pancreas is a small yet critical organ — a gland approximately 15 cm long, shaped like an elongated pear, hidden deep in the abdomen between the stomach and spine. It produces digestive enzymes essential for breaking down food and hormones — including insulin — that regulate blood sugar. When cancer develops in this organ, the consequences are devastating: over 90% of cases are diagnosed only after the tumour has spread to surrounding tissues, lymph nodes, or distant organs.

Fig. 1. Pancreas structure: head (widest part, near duodenum), body (middle), and tail (narrow end, near spleen).

Warning Signs You Should Not Ignore

Pancreatic cancer is insidious because early-stage disease often causes no symptoms or produces only vague, non-specific complaints. Most patients experience one or more of the following:

Primary Symptoms

• Abdominal or back pain — more common in tumours of the body or tail. Pain is often dull and gnawing, radiates to the sides or back, and worsens after eating or when lying down.
• Jaundice — occurs when a tumour in the head of the pancreas blocks the bile duct. Causes yellowing of skin and eyes, dark urine, pale/greasy stools, and itchy skin.
• Unexplained weight loss — often with loss of appetite, especially in head-of-pancreas tumours.
• Stool changes — pale, fatty, foul-smelling stools that are hard to flush (steatorrhoea), indicating impaired fat absorption. Diarrhoea or constipation may also occur.
• Indigestion — heartburn, bloating, nausea.

Associated Conditions

• Deep vein thrombosis (DVT) — pancreatic cancer promotes clotting by releasing tissue factor and thrombin. Symptoms: leg pain, swelling, redness. If a clot reaches the lungs — pulmonary embolism (chest pain, breathlessness).
• New-onset diabetes — the tumour destroys insulin-producing islet cells. Manifests as increased thirst, hunger, and frequent urination.
• Enlarged gallbladder — a blocked bile duct causes bile accumulation.

Advanced-Stage Symptoms

• Liver metastases — right-sided abdominal pain, ascites (fluid build-up).
• Lung metastases — persistent cough, shortness of breath, recurring infections, haemoptysis.
• Bone metastases — fragile bones, hypercalcaemia (dehydration, confusion, nausea), anaemia.

Staging

Fig. 2. Pancreatic cancer stages: from in situ changes (stage 0) to distant metastases (stage IV).

• Stage 0 (carcinoma in situ) — abnormal cells found only in the pancreatic lining.
• Stage I — cancer confined to the pancreas; surgically removable (resectable).
• Stage II — may extend slightly beyond the pancreas (e.g. nearby lymph nodes); resectable or borderline resectable.
• Stage III — locally advanced, involving major arteries; surgical removal difficult.
• Stage IV — metastatic spread to distant organs (liver, lungs); surgery will not cure.

Risk Factors

Genetics and Family History

Up to 15% of pancreatic cancer cases have a familial link. A first-degree relative with pancreatic cancer increases risk 2–3 fold. BRCA1, BRCA2, PALB2, ATM mutations and genetic syndromes (Lynch, Peutz-Jeghers, hereditary pancreatitis) significantly elevate susceptibility.

Lifestyle (Modifiable)

• Smoking — accounts for 20–25% of cases, doubles the risk. Tumours in smokers grow faster and appear ~10 years earlier. After 20 years of cessation, risk returns to that of never-smokers.
• Obesity — BMI >25–30 increases risk. Maintaining a healthy weight is protective.
• Alcohol — ≥3 standard drinks per day can cause chronic pancreatitis and raise cancer risk.
• High sugar intake — a 2019 study found that high-sugar environments increase the likelihood of cancer-driving mutations by 5-fold.
• Nighttime artificial light — a 2021 study: highest levels of artificial light at night linked to 27% higher pancreatic cancer risk.
• Chemical exposure — asbestos, pesticides, dyes, petrochemicals. Ionising radiation — small risk increase.

Medical Conditions

• Chronic pancreatitis — long-term organ inflammation.
• Gallstones — may lead to chronic pancreatitis.
• Diabetes — 2-fold risk increase (in some cases diabetes may be an early symptom rather than a cause).
• Insulin resistance and metabolic syndrome
• Polycystic ovary syndrome (PCOS) — 2024 study: 38% higher pancreatic cancer risk.
• Infections — hepatitis B, H. pylori, periodontal bacteria.
• COVID-19 — 2020 study showed SARS-CoV-2 S2 protein interaction with BRCA1/BRCA2 tumour suppressors.

Other Factors

• Age — most diagnoses between 60–80; Gen X and Millennials face higher risk than older generations.
• Sex — men slightly more often (greater tobacco and alcohol exposure).
• Ethnicity — Ashkenazi Jews (BRCA mutations), African Americans — higher risk.
• Blood type — A (+32%), AB (+51%), B (+72%) vs O.
• Height — taller adults may have higher risk (mechanism unclear).

Diagnosis

Pancreatic cancer has no routine population screening — current methods cannot reliably detect it early in asymptomatic individuals. However, high-risk patients may benefit from:

• CT scan — detailed imaging of the pancreas and surroundings.
• Endoscopic ultrasound (EUS) — close-up imaging with biopsy capability.
• MRCP — detailed MRI of pancreas and bile ducts.
• ERCP — endoscopy combined with X-ray; can biopsy and clear blockages.
• Tumour markers (CA 19-9, CEA) — elevated blood levels may indicate cancer.
• PET-CT — identifies cancer foci based on glucose metabolism.
• Genetic testing — for hereditary mutations (BRCA, PALB2, ATM).
• Laparoscopy — direct visualisation of abdominal organs.
• Biopsy — tissue sampling for microscopic examination.

Conventional Treatment

Surgery

• Whipple procedure (pancreaticoduodenectomy) — most common for head-of-pancreas tumours. Removes the head of the pancreas, part of the small intestine, gallbladder, bile duct, and sometimes part of the stomach.
• Distal pancreatectomy — for body/tail tumours; removes the affected portion and often the spleen.
• Total pancreatectomy — rare; requires lifelong insulin and digestive enzyme replacement.
• Palliative (bypass) surgery — to relieve obstructed ducts when the tumour is unresectable.

Chemotherapy

Used neoadjuvantly (before surgery), adjuvantly (after surgery), or as primary treatment in advanced disease. Common regimens include FOLFIRINOX and gemcitabine. Side effects: hair loss, nausea, fatigue, reduced immunity.

Radiation Therapy

High-energy beams damage cancer cell DNA. Can shrink tumours before surgery, eliminate residual cells after surgery, or control growth and alleviate symptoms.

Immunotherapy

Helps the immune system recognise and attack cancer cells. Still under investigation for pancreatic cancer, but some drugs have received FDA approval.

Targeted Therapy

Blocks specific molecules involved in tumour growth. Used for unresectable pancreatic cancer based on tumour genetic testing results.

Pulsed Electric Field (PEF) Therapy

Non-invasive method using short high-voltage pulses to disrupt cancer cell membranes without damaging healthy tissue. A 2023 study showed that nano-pulsed PEF reduced drug resistance in pancreatic cancer cells and increased their sensitivity to chemotherapy.

Herbs, Natural Substances and Alternative Medicine in Pancreatic Cancer

This section forms the most extensive part of the article — and rightly so. For many patients with inoperable pancreatic cancer, conventional options are limited, and integrative methods may improve quality of life, reduce chemotherapy side effects and — in some research-documented cases — extend survival. All substances and methods described below should be treated as complementary to, not a replacement for, oncological treatment.

Fig. 3. Overview of natural substances with research evidence in pancreatic cancer.

1. Curcumin (Curcuma longa)

Scientific evidence:

• A 2025 systematic review (MDPI Cancers, "Unconventional Treatments for Pancreatic Cancer") confirmed that curcumin used alongside standard therapy is associated with improved survival and quality of life.
• A 2025 multi-dimensional analysis (PMC) showed that curcumin induces pancreatic cancer cell apoptosis via CerS1-dependent endoplasmic reticulum stress.
• Curcumin inhibits tumour angiogenesis and sensitises cancer cells to gemcitabine — the most commonly used chemotherapy agent in pancreatic cancer.

Dosage and bioavailability: The main challenge is curcumin's poor oral bioavailability. Solutions include liposomal formulations, nano-curcumin, and co-administration with piperine (a black pepper component that increases absorption 20-fold). Clinical trials have used doses of 2–8 g/day.

2. Mistletoe Extract (Viscum album)

Scientific evidence:

• 2014 study — 96 pancreatic cancer patients receiving mistletoe extract injections 3× weekly experienced significant reductions in pain, fatigue, appetite loss, and insomnia. The extract was assessed as a potentially effective second-line therapy.
• MISTRAL trial (2024) — randomised, placebo-controlled, double-blind study in patients with advanced pancreatic cancer. Investigated whether mistletoe extract added to comprehensive oncological treatment prolongs overall survival (OS) and improves health-related quality of life (HRQoL).
• 2023 hyperthermia study (MDPI Cancers) — patients receiving mistletoe and hyperthermia in addition to palliative chemotherapy showed favourable clinical outcomes.
• Additional studies found that mistletoe extract may also prolong survival time in pancreatic cancer patients.

Administration: Subcutaneous injections 2–3× weekly with gradually increasing doses. Available in many EU countries by prescription or as an anthroposophic preparation.

3. Traditional Chinese Medicine (TCM)

Scientific evidence:

• 2019 study (182 pancreatic cancer patients) — patients treated with Chinese herbal medicine, including St John's wort, Ginkgo biloba, and ginseng, achieved a median survival of nearly 30 months — far above the typical median for advanced pancreatic cancer (6–12 months).
• 2017 population-based study — Bai-hua-she-she-cao (Hedyotis diffusa) and Xiang-sha-liu-jun-zi-tang (Costus and Chinese Amomum Combination) were associated with improved survival and reduced mortality risk.
• 2023 review (PMC, "Advances in the treatment of pancreatic cancer with TCM") — confirmed multi-pathway mechanisms of Chinese herbs: apoptosis induction, proliferation inhibition, tumour microenvironment modulation, and drug resistance reduction.

Key TCM herbs in pancreatic cancer:

• Hedyotis diffusa — cytotoxic and antiproliferative
• Panax ginseng — immunomodulatory, anti-fatigue
• Ginkgo biloba — antioxidant, neuroprotective
• Scutellaria baicalensis (Baikal skullcap) — contains baicalein, a potent NF-κB inhibitor
• Glycyrrhiza glabra (liquorice) — contains isoliquiritigenin with pro-apoptotic activity

4. Medicinal Mushrooms

Key species:

• Ganoderma lucidum (reishi) — immunostimulatory and anti-tumour properties. A Cochrane review (2016) confirmed reishi may be used as an adjunct to conventional oncological treatment. Contains cytotoxic triterpenoids.
• Trametes versicolor (turkey tail) — PSK (krestin) polysaccharide approved in Japan as an oncology adjuvant since the 1980s. Enhances NK cell and T lymphocyte activity.
• Grifola frondosa (maitake) — D and MD fractions show anti-tumour activity in animal models of pancreatic cancer.
• Lentinula edodes (shiitake) — lentinan used intravenously in Japan as an immunomodulator for GI tract cancers.
• Hericium erinaceus (lion's mane) — in vitro studies demonstrate growth inhibition of pancreatic cancer cells.

Usage: As supplementation in the form of extracts standardised to β-glucans (min. 30%). Quality and standardisation are crucial — not all products on the market are equivalent.

5. Cannabinoids (CBD, THC)

Scientific evidence:

• 2020 study (MDPI Int J Mol Sci) — CBD and THC inhibited proliferation of pancreatic cancer cells (PC), pancreatic stellate cells (PSC), and PSC-stimulated PC cells. They suppressed pancreatic tumour growth in mice and reduced PD-L1 expression — a protein that enables cancer cells to evade the immune system.
• 2025 study (MDPI Int J Mol Sci) — CBD improved survival in a mouse model of pancreatic cancer by modulating bile acid profiles and gut microbiota.
• 2025 review (Springer, Cell Cancer) — CBD exhibits anti-cancer properties via multiple pathways: CerS1-mediated ER stress, GPR55/MAPK inhibition, immune modulation, and chemosensitisation to gemcitabine.
• CanPan pilot trial — a randomised clinical trial evaluating medical cannabis for symptom reduction in newly diagnosed pancreatic cancer patients.

Note: CBD and THC do not replace chemotherapy. They may, however, alleviate pain, nausea, appetite loss, and insomnia — common problems in pancreatic cancer patients. Use requires medical consultation and consideration of legal status in the relevant jurisdiction.

6. High-Dose Intravenous Vitamin C

Key study (2024):

• Stage IV pancreatic cancer patients receiving chemotherapy + high-dose IV vitamin C lived twice as long: 16 months vs 8 months compared to the chemotherapy-only group.
• They had fewer chemotherapy side effects.
• Better treatment schedule adherence (fewer delays and dose reductions).

Mechanism: At pharmacological concentrations, vitamin C acts as a pro-oxidant — generating hydrogen peroxide that is toxic to cancer cells (which have low catalase levels) but does not harm healthy cells.

7. Resveratrol

• Inhibits proliferation and induces apoptosis via modulation of Bcl-2 family proteins (MDPI Molecules, 2021).
• Inhibits hypoxia-induced pancreatic stellate cell activation — a key mechanism of pancreatic cancer progression (PMC, 2020).
• Suppresses pancreatic cancer by inhibiting leukotriene A4 hydrolase (LTA4H) — a pro-inflammatory enzyme (PMC, 2016).
• Resveratrol derivatives show even stronger antiproliferative effects, targeting cancer stem cells (MDPI Int J Mol Sci, 2023).

Limitations: Like curcumin, resveratrol has low oral bioavailability. Clinical trials use doses of 500 mg–5 g/day, often as trans-resveratrol.

8. Quercetin

• A 2021 review (PMC) confirmed that quercetin modulates multiple pathways involved in pancreatic cancer progression, including apoptosis, autophagy, and cell cycle regulation.
• A 2022 study showed that quercetin improves pancreatic cancer chemosensitivity by regulating oxidative-inflammatory networks, reducing immunosuppression in the tumour microenvironment.
• Combined with gemcitabine, it shows synergistic effects — reducing drug resistance.

9. Berberine

• A 2022 study demonstrated that berberine exhibits activity against both pancreatitis and pancreatic cancer — inhibiting proliferation and inducing apoptosis of cancer cells.
• Mechanisms: AMPK modulation, NF-κB inhibition, autophagy induction, multi-drug resistance reduction.
• In animal models, berberine reduced pancreatic tumour volume and inhibited metastasis.

10. Flavonoids — EGCG, Apigenin, Baicalein, Wogonin, Silibinin

• EGCG (epigallocatechin gallate) — the primary polyphenol in green tea. Inhibits LDHA, an enzyme critical for cancer cell metabolism. Regular green tea consumption is associated with reduced pancreatic cancer risk.
• Apigenin — found in parsley, celery, chamomile. Inhibits proliferation and induces apoptosis in pancreatic cancer cells.
• Baicalein — from Baikal skullcap. Potent NF-κB inhibitor, inhibits tumour angiogenesis.
• Wogonin — also from Baikal skullcap. Induces apoptosis and autophagy in pancreatic cancer cells.
• Silibinin — from milk thistle (Silybum marianum). Inhibits cancer cell growth and reduces resistance to chemotherapeutics.
• Isoliquiritigenin — from liquorice root. Pro-apoptotic and antiproliferative against pancreatic cancer cells.

11. Apitherapy (Bee Venom)

A 2022 study showed that bee venom slows pancreatic cancer cell progression. Key peptides under investigation:

• Melittin — the main component of bee venom. Induces cancer cell apoptosis, disrupts mitochondrial membranes, inhibits angiogenesis.
• Apamin — blocks calcium-activated potassium channels. Researchers are investigating its potential as a tumour microenvironment modulator.

12. Ivermectin + Gemcitabine

2022 study:

• The ivermectin + gemcitabine combination was more effective at suppressing pancreatic cancer than gemcitabine alone.
• The combination reduced cancer cell growth, lowered oxygen consumption, and blocked mitophagy — a process cancer cells use to survive.
• In animal models — significant reduction in tumour growth.

Acupuncture and Electroacupuncture

Acupuncture and electroacupuncture are recommended by ASCO (American Society of Clinical Oncology) as integrative methods to support cancer treatment. The 2025 systematic review (MDPI Cancers) included electroacupuncture in the list of unconventional therapies for pancreatic cancer.

• Pain reduction — especially neuropathic pain and coeliac plexus infiltration pain.
• Reduction of chemotherapy-induced nausea and vomiting.
• Appetite improvement and fatigue reduction.
• Anxiety relief and improved sleep quality.

Diet and Nutrition

Nutritional Principles

• Frequent, small meals — 6–8 daily at regular times. Don't wait until hungry.
• Hydration — plenty of clear fluids: water, electrolytes, broth.
• Limit sugar and fat — stabilise blood glucose, pair carbohydrates with protein (fish, poultry, legumes). Limit fatty foods that strain the pancreas.
• Avoid high-temperature cooking — frying and grilling generate carcinogenic compounds (acrylamide, HCA, PAH). Prefer baking, steaming, poaching.

Intermittent Fasting

Lab studies show fasting can increase gemcitabine uptake by pancreatic cancer cells by raising a transport protein, improving treatment effectiveness. Combining fasting with gemcitabine reduced tumour growth by over 40% in lab models. Caution: most patients benefit from regular small meals. Fasting should only be undertaken under medical supervision.

Vitamin Supplementation

• B vitamins (B1, B3, B6) — pancreatic cancer patients have elevated risk of water-soluble vitamin deficiencies.
• Fat-soluble vitamins (A, D, E, K) — impaired fat absorption leads to deficiency.
• Pancreatic enzymes (PERT) — digestive enzyme supplementation is critical in exocrine pancreatic insufficiency.

Physical Activity

Gentle exercise helps maintain strength, mobility, and mood. A 2022 study found that the same biochemical pathways activated by aerobic exercise to repair muscle damage may also help shrink pancreatic tumours and increase their sensitivity to immunotherapy.

• Short walks
• Light housework and gardening
• Seated leg raises
• Lifting light objects
• Walking up and down stairs
• Tai chi — combining gentle movement with meditation and deep breathing

Stress Management

Chronic stress weakens the immune system and disrupts metabolic-hormonal balance, potentially creating conditions that favour tumour growth and spread.

• Mindfulness meditation — clinical trials confirm reductions in anxiety, depression, and fatigue in cancer patients.
• Breathing exercises — vagus nerve activation, cortisol reduction.
• Yoga — studies show reduced anxiety, depression, stress, and fatigue in cancer survivors with improved sleep quality.
• Tai chi and qigong — gentle movement forms combining exercise with relaxation techniques.
• Psychological support — support groups, cognitive-behavioural therapy, psycho-oncology counselling.

Probiotics and Gut Microbiota

Restoring a healthy gut bacterial balance through prebiotics, probiotics, next-generation probiotics, or faecal microbiota transplantation may help reduce inflammation and support gut health — relevant because gut dysbiosis has been linked to pancreatic cancer progression.

Prevention — How to Reduce Your Risk

• Stop smoking — the single most important modifiable risk factor.
• Maintain a healthy weight — diet rich in vegetables, fruits, whole grains.
• Limit alcohol — max 1–2 units per day.
• Drink green tea — EGCG disrupts pancreatic cancer cell metabolism by inhibiting LDHA.
• Genetic counselling — if you have a family history.
• Regular check-ups — especially with risk factors.
• Diabetes control — maintain normal blood glucose.
• Stress reduction — meditation, physical activity.
• Oral health — periodontal disease is linked to higher risk.

Complications of Pancreatic Cancer

• Pain — frequent, severe, radiating to the back.
• Spleen enlargement — body/tail tumours blocking the splenic vein.
• Oesophageal varices — risk of massive bleeding.
• Diabetes — up to 50% of patients develop secondary diabetes.
• Malabsorption — bloating, fatty diarrhoea, weight loss, vitamin deficiencies.
• Bowel obstruction — tumour blocks food passage.
• Biliary obstruction — obstructive jaundice.
• Venous thromboembolism — pancreatic tumours promote blood clotting.

Integrative Approach to Pancreatic Cancer

flowchart TD
    A[Pancreatic Cancer Diagnosis] --> B{Stage?}
    B -->|I-II resectable| C[Surgery + adjuvant chemo]
    B -->|III locally advanced| D[Chemotherapy ± radiation]
    B -->|IV metastatic| E[Palliative chemotherapy]
    
    C --> F[Integrative supportive therapies]
    D --> F
    E --> F
    
    F --> G[Natural substances]
    F --> H[Mind-body methods]
    F --> I[Therapeutic nutrition]
    
    G --> G1[Curcumin]
    G --> G2[Mistletoe]
    G --> G3[Medicinal mushrooms]
    G --> G4[CBD/THC]
    G --> G5[IV Vitamin C]
    G --> G6[Flavonoids]
    
    H --> H1[Acupuncture]
    H --> H2[Meditation/Yoga]
    H --> H3[Tai chi]
    
    I --> I1[Small meals 6-8x]
    I --> I2[Enzyme supplementation]
    I --> I3[Vitamins B + ADEK]